OR WAIT null SECS
Growth and Advancements in Fill/Finish
Leveraging automation advancements can help improve efficiency in aseptic processing.
Changes and Trends in the Outsourcing Landscape
Quality Considerations in Changing Excipient Providers
March 08, 2024
EMA plans to add 10 partners to its real-world data initiative, DARWIN EU, in 2024.
March 07, 2024
Johnson & Johnson’s $2 billion acquisition of Ambrx boosts its pipeline of next-generation ADCs for cancer treatment.
FDA has published final guidance documents regarding validation and development of analytical procedures.
New plans laid out by AstraZeneca will see £650 million ($828 million) be invested into the UK.
Sean Knight, Simtra BioPharma Solutions, reacts to the company's global expansion efforts and investment in sterile fill/finish.
Cellares CEO Fabian Gerlinghaus shares how an automated, closed-production platform with a small footprint can dramatically impact cost savings and scalability for cell and gene therapies.
March 06, 2024
Under a global license and collaboration agreement, AbbVie and OSE Immunotherapeutics will aim to develop OSE-230, a mAb for treating chronic inflammation.
The company is expanding GMP capacities at its Frankfurt site to manufacture early clinical-phase peptide APIs.
March 05, 2024
March 04, 2024
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.